Back to UBS Group AG UBS Group AG

INOINO
Showing 8 of 10 quarters

Position history for UBS Group AGUBS Group AG's holdings in INOVIO PHARMACEUTICALS INC

Yes. Ubs holds 262,320 shares of INO (Inovio Pharmaceuticals), worth $288,552, as of its Q2 2026 13F filing. It increased the position by 12,670 shares (+5.1%) from Q1 2026. Ubs has held INO in every 13F on record since Q1 2024, 10 quarterly filings.

Current Value

$288,552

Current Shares

262,320

Total Value Change

+$209,280

Total Shares Change

+248,605

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
262,320
+5.1%
$288,5520.0%$1.10
17
2026-Q1
Increased
249,650
+46.4%
$434,3920.0%$1.74
33
2025-Q4
Decreased
170,579
-41.8%
$296,8080.0%$1.74
0
2025-Q3
Increased
293,062
+46.8%
$685,7650.0%$2.34
34
2025-Q2
Decreased
199,679
-3.9%
$406,3480.0%$2.04
0
2025-Q1
Increased
207,867
+17.5%
$338,8230.0%$1.63
28
2024-Q4
Increased
176,974
+1190.4%
$323,8630.0%$1.83
38
2024-Q3
Decreased
13,715
-49.9%
$79,2720.0%$5.78
0

Other major holders of INO: FMR LLC, BlackRock Finance, Inc., BlackRock, Inc., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used